These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6168090)

  • 1. Practical utility of specific red cell adherence test in bladder cancer.
    Catalona WJ
    Urology; 1981 Aug; 18(2):113-7. PubMed ID: 6168090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A, B and O(H) isoantigens in tumor of the urinary bladder. Preliminary results, relating the specific red cell adherence test to pathological grade and stage.
    Karlsen S; Jordfald G; Svaar H
    Urol Int; 1984; 39(3):150-3. PubMed ID: 6740805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].
    Ogawa T; Sugimoto M; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):13-25. PubMed ID: 2729014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.
    Alroy J; Teramura K; Miller AW; Pauli BU; Gottesman JE; Flanagan M; Davisohn I; Weinstein RS
    Cancer; 1978 May; 41(5):1739-45. PubMed ID: 647623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxidase antiperoxidase versus specific red cell adherence in detection of O (H) antigen in bladder cancer: a blind study.
    Javadpour N; Vafrier J; Worsham GF; O'Connel K
    J Surg Oncol; 1984 Oct; 27(2):112-5. PubMed ID: 6384666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
    Selli C; Cozzolino F; Vercelli D; Mincione GP
    Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO(H) isoantigens in bladder tumors: a new technique of quantitative analysis.
    Srinivas V; Kiruluta HG
    J Urol; 1984 Feb; 131(2):245-8. PubMed ID: 6699953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific red cell adherence test in transitional cell carcinoma of the bladder before and after radiotherapy in patients with blood group A.
    Wolk FN; Bishop MC
    J Urol; 1983 Jul; 130(1):71-3. PubMed ID: 6345808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.
    Flanigan RC; King CT; Clark TD; Cash JB; Greenfield BJ; Sniecinski IJ; Primus FJ
    J Urol; 1983 Sep; 130(3):499-503. PubMed ID: 6350617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group antigens and bladder carcinoma: a perspective.
    Stein BS; Kendall AR
    Urology; 1982 Sep; 20(3):229-33. PubMed ID: 7123712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific erythrocyte adherence reaction: an index of the malignant potentials of noninvasive tumors of the human urothelium].
    Anichkov NM; Anichkova SI
    Vopr Onkol; 1980; 26(8):9-13. PubMed ID: 7415061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the methods of indirect immunofluorescence and specific red cell adherence in detecting ABH iso-antigens in bladder carcinoma.
    Cooper HS; D'Elia FL
    Am J Clin Pathol; 1982 May; 77(5):548-54. PubMed ID: 7044101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific red cell adherence: immunologic evaluation of random mucosal biopsies in carcinoma of the bladder.
    Stein BS; Reyes JM; Petersen RO; McNellis D; Kendall AR
    J Urol; 1981 Jul; 126(1):37-40. PubMed ID: 6166759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma.
    Sadoughi N; Mlsna J; Guinan P; Rubenstone A
    Urology; 1982 Aug; 20(2):143-6. PubMed ID: 7051508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of erythrocyte adherence tests (SRCA tests) in the diagnosis and therapy of superficial bladder tumors].
    Jakse G; Hofstädter F
    Helv Chir Acta; 1981 Aug; 48(3-4):499-501. PubMed ID: 7026511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface antigen in bilharzial bladder tumours.
    Halim A; Javadpour N; Kasraeian A; Young JD
    Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.
    Newman AJ; Carlton CE; Johnson S
    J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.